Creating educational tools for informed decision-making about multi-cancer early detection tests
Supporting Informed Decision Making About Multi-cancer Early Detection Testing
M.D. Anderson Cancer Center · NCT06870916
This study is trying to create helpful educational tools to assist adults in making informed choices about new blood tests that can detect multiple types of cancer early.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 21 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center (other) |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06870916 on ClinicalTrials.gov |
What this trial studies
This project aims to develop a participant educational aid to help individuals make informed decisions regarding Multi-Cancer Early Detection (MCED) tests, which are innovative blood-based screening methods. The approach involves conducting focus groups to gather insights on preferences and concerns related to MCED testing among adults of screening age. Based on the findings from these discussions, surveys will be administered to further explore these themes, ultimately leading to the creation of a user-centered educational prototype. The goal is to enhance understanding and facilitate informed choices about cancer screening.
Who should consider this trial
Good fit: Ideal candidates for this project are adults of screening age who are considering multi-cancer early detection testing.
Not a fit: Patients with a history of cancer other than basal cell and squamous cell skin cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could empower patients with better knowledge and understanding of multi-cancer early detection tests, leading to more informed health decisions.
How similar studies have performed: While the approach of developing educational aids is common, the specific focus on MCED testing is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • Recruitment and eligibility will be assessed by CCETR.CCETR staff will help distribute recruitment flyers, assess subject eligibility, and refer eligible subjects to the research team (Appendix B, C \& I). Exclusion Criteria: • History of cancer other than basil cell and squamous cell skin cancer, per self-report.
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Robert Volk, PHD — M.D. Anderson Cancer Center
- Study coordinator: Robert Volk, PHD
- Email: bvolk@mdanderson.org
- Phone: 713-563-2509
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Multi-cancer Early Detection